Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Hypertension does not directly cause dyspnoea; however it can lead to long-term effects on the heart and arteries ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...

Not everybody with blockages needs surgical intervention. Guidelines recommend against surgery in people with no symptoms and ...

Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying ...

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated.

A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...

It causes the blood vessel walls to thicken and stiffen, meaning less blood can pass through. Pulmonary hypertension can damage the right side of the heart and increase pressure in the superior ...

In April 2025, Actelion announced a study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the ...